{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:03:14Z","timestamp":1794016994098,"version":"4.8.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004032","name":"Jilin University","doi-asserted-by":"publisher","award":["2025CX307"],"award-info":[{"award-number":["2025CX307"]}],"id":[{"id":"10.13039\/501100004032","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011789","name":"Department of Science and Technology of Jilin Province","doi-asserted-by":"publisher","award":["YDZJ202501ZYTS075"],"award-info":[{"award-number":["YDZJ202501ZYTS075"]}],"id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.tranon.2026.102930","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T09:09:42Z","timestamp":1785143382000},"page":"102930","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["IGHG1\u207a plasma cells define an NF-\u03baB-driven inflammatory program that shapes T-cell immunity and immunotherapy response in colorectal cancer"],"prefix":"10.1016","volume":"72","author":[{"given":"Rui-Feng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Ze","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rulei","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3210-5395","authenticated-orcid":false,"given":"Jian-Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.tranon.2026.102930_bib0001","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"8","key":"10.1016\/j.tranon.2026.102930_bib0002","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.ccell.2024.07.005","article-title":"Integrative plasma and fecal metabolomics identify functional metabolites in adenoma-colorectal cancer progression and as early diagnostic biomarkers","volume":"42","author":"Sun","year":"2024","journal-title":"Cancer Cell."},{"issue":"23","key":"10.1016\/j.tranon.2026.102930_bib0003","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","article-title":"Pembrolizumab in microsatellite-instability-high advanced colorectal cancer","volume":"383","author":"Andre","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"6230","key":"10.1016\/j.tranon.2026.102930_bib0004","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1126\/science.aaa8172","article-title":"The future of immune checkpoint therapy","volume":"348","author":"Sharma","year":"2015","journal-title":"Science"},{"issue":"6694","key":"10.1016\/j.tranon.2026.102930_bib0005","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.adh7954","article-title":"Vitamin D regulates microbiome-dependent cancer immunity","volume":"384","author":"Giampazolias","year":"2024","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.tranon.2026.102930_bib0006","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.tranon.2026.102930_bib0007","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1158\/2159-8290.CD-20-1808","article-title":"Therapeutic targeting of the tumor microenvironment","volume":"11","author":"Bejarano","year":"2021","journal-title":"Cancer Discov."},{"issue":"7949","key":"10.1016\/j.tranon.2026.102930_bib0008","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/s41586-022-05626-9","article-title":"Functional T cells are capable of supernumerary cell division and longevity","volume":"614","author":"Soerens","year":"2023","journal-title":"Nature"},{"issue":"6667","key":"10.1016\/j.tranon.2026.102930_bib0009","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1126\/science.add7034","article-title":"Probiotic-guided CAR-T cells for solid tumor targeting","volume":"382","author":"Vincent","year":"2023","journal-title":"Science"},{"issue":"7791","key":"10.1016\/j.tranon.2026.102930_bib0010","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"issue":"7801","key":"10.1016\/j.tranon.2026.102930_bib0011","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2155-6","article-title":"Author correction: tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"580","author":"Cabrita","year":"2020","journal-title":"Nature"},{"issue":"7791","key":"10.1016\/j.tranon.2026.102930_bib0012","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41586-019-1906-8","article-title":"B cells are associated with survival and immunotherapy response in sarcoma","volume":"577","author":"Petitprez","year":"2020","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.tranon.2026.102930_bib0013","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","article-title":"Tertiary lymphoid structures in the era of cancer immunotherapy","volume":"19","author":"Saut\u00e8s-Fridman","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"24","key":"10.1016\/j.tranon.2026.102930_bib0014","doi-asserted-by":"crossref","first-page":"6125","DOI":"10.1158\/1078-0432.CCR-18-1481","article-title":"Prognostic significance of tumor-infiltrating B cells and plasma cells in Human cancer","volume":"24","author":"Wouters","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.tranon.2026.102930_bib0015","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.immuni.2022.02.001","article-title":"Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer","volume":"55","author":"Meylan","year":"2022","journal-title":"Immunity"},{"issue":"8039","key":"10.1016\/j.tranon.2026.102930_bib0016","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s41586-024-07571-1","article-title":"Single-cell integration reveals metaplasia in inflammatory gut diseases","volume":"635","author":"Oliver","year":"2024","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.tranon.2026.102930_bib0017","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","article-title":"Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer","volume":"39","author":"Bindea","year":"2013","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.tranon.2026.102930_bib0018","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1158\/0008-5472.CAN-23-3325","article-title":"Exploiting tertiary lymphoid structures to stimulate antitumor immunity and improve immunotherapy efficacy","volume":"84","author":"Petroni","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.tranon.2026.102930_bib0019","article-title":"Tertiary lymphoid structures: new immunotherapy biomarker","volume":"15","author":"Yang","year":"2024","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.tranon.2026.102930_bib0020","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.ccell.2024.06.009","article-title":"Spatiotemporal single-cell analysis decodes cellular dynamics underlying different responses to immunotherapy in colorectal cancer","volume":"42","author":"Chen","year":"2024","journal-title":"Cancer Cell."},{"issue":"1","key":"10.1016\/j.tranon.2026.102930_bib0021","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13059-017-1382-0","article-title":"SCANPY: large-scale single-cell gene expression data analysis","volume":"19","author":"Wolf","year":"2018","journal-title":"Genome Biol."},{"issue":"12","key":"10.1016\/j.tranon.2026.102930_bib0022","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat. Methods"},{"issue":"1","key":"10.1016\/j.tranon.2026.102930_bib0023","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41746-025-02297-4","article-title":"Integrative single-cell and spatial transcriptomics with explainable AI reveal lethal prognostic axis in prostate cancer","volume":"9","author":"Ge","year":"2026","journal-title":"NPJ. Digit. Med."},{"issue":"11","key":"10.1016\/j.tranon.2026.102930_bib0024","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.7150\/thno.109097","article-title":"Spatially segregated APOE(+) macrophages restrict immunotherapy efficacy in clear cell renal cell carcinoma","volume":"15","author":"Ge","year":"2025","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.tranon.2026.102930_bib0025","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.1038\/s41467-024-50194-3","article-title":"OmicVerse: a framework for bridging and deepening insights across bulk and single-cell sequencing","volume":"15","author":"Zeng","year":"2024","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.tranon.2026.102930_bib0026","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/j.ccell.2024.09.011","article-title":"A pan-cancer single-cell RNA-seq atlas of intratumoral B cells","volume":"42","author":"Fitzsimons","year":"2024","journal-title":"Cancer Cell."},{"issue":"5","key":"10.1016\/j.tranon.2026.102930_bib0027","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"issue":"1","key":"10.1016\/j.tranon.2026.102930_bib0028","article-title":"Regulatory B cells promote the immunosuppressive microenvironment and progression of clear cell renal cell carcinoma","volume":"5","author":"Ge","year":"2024","journal-title":"Immun. Other Adv."},{"issue":"3","key":"10.1016\/j.tranon.2026.102930_bib0029","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","article-title":"A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells","volume":"184","author":"Cheng","year":"2021","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.tranon.2026.102930_bib0030","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41588-024-01998-y","article-title":"Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer","volume":"57","author":"Yan","year":"2025","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tranon.2026.102930_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2025.102464","article-title":"Treatment of colorectal peritoneal metastases with oxaliplatin induces biomarkers predicting response to immune checkpoint blockade","volume":"59","author":"Constantinides","year":"2025","journal-title":"Transl. Oncol."},{"issue":"7\u20138","key":"10.1016\/j.tranon.2026.102930_bib0032","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/1751-2980.70001","article-title":"CXCL13 as a prognostic biomarker and modulator of the tumor microenvironment in colorectal cancer","volume":"26","author":"Guo","year":"2025","journal-title":"J. Dig. Dis."},{"issue":"10","key":"10.1016\/j.tranon.2026.102930_bib0033","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1158\/2326-6066.CIR-17-0075","article-title":"Antigen-presenting intratumoral B cells affect CD4(+) TIL phenotypes in non-small cell lung cancer patients","volume":"5","author":"Bruno","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.tranon.2026.102930_bib0034","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ejca.2021.03.054","article-title":"CXCL13 shapes tertiary lymphoid structures and promotes response to immunotherapy in bladder cancer","volume":"151","author":"Rouanne","year":"2021","journal-title":"Eur. J. Cancer"},{"issue":"12","key":"10.1016\/j.tranon.2026.102930_bib0035","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aay1357","article-title":"Recruitment of CD103(+) dendritic cells via tumor-targeted chemokine delivery enhances efficacy of checkpoint inhibitor immunotherapy","volume":"5","author":"Williford","year":"2019","journal-title":"Sci. Adv."},{"issue":"23","key":"10.1016\/j.tranon.2026.102930_bib0036","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMe2031294","article-title":"Pembrolizumab in MSI-H-dMMR advanced colorectal cancer - a new standard of care","volume":"383","author":"Grothey","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.tranon.2026.102930_bib0037","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1158\/1078-0432.CCR-21-1130","article-title":"B cells and tertiary lymphoid structures: friends or foes in cancer immunotherapy?","volume":"28","author":"Lauss","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tranon.2026.102930_bib0038","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.954936","article-title":"Role of B cells as antigen presenting cells","volume":"13","author":"Rastogi","year":"2022","journal-title":"Front. Immunol."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326002664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326002664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:43:54Z","timestamp":1790739834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326002664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":38,"alternative-id":["S1936523326002664"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102930","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IGHG1\u207a plasma cells define an NF-\u03baB-driven inflammatory program that shapes T-cell immunity and immunotherapy response in colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102930","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102930"}}